Vilija Jokubaitis

Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.

Tomas Kalincik, Ibrahima Diouf, Sifat Sharmin, Charles Malpas, Tim Spelman, Dana Horakova, Eva Kubala Havrdova, Maria Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Vilija Jokubaitis, Anneke van der Walt, Francois Grand'Maison, Patrizia Sola, Diana Ferraro, Vahid Shaygannejad, et al.

Journal article  |  2021  |  Neurology

OBJECTIVE: To test the hypothesis that immunotherapy prevents long-term disability in relapsing-remitting multiple sclerosis (MS),..

Assessing Patient Preference: Preferred Time and Location of Infusible Therapies in Multiple Sclerosis and Neuroimmunologic Disorders

Louise Rath, Maria Pia Campagna, Jim Stankovich, Julian Ellis, Vilija Jokubaitis, Denise McCarthy, Cassie Nesbitt, Wei Zhen Yeh, Michael Zhong, Robb Wesselingh, Mastura Monif, Janene Richards, Viet Bui Minh, Olga Skibina, Helmut Butzkueven, Anneke van der Walt

Journal article  |  2020  |  International Journal of MS Care

Abstract Background: People with multiple sclerosis and neuroimmunologic disorders (herein referred to as patients)..

Association of Pregnancy With the Onset of Clinically Isolated Syndrome

Nguyen Ai-Lan, Karolina Vodehnalova, Tomas Kalincik, Alessi Signori, Eva Kubala Havrdova, Jeannette Lechner-Scott, Olga G Skibina, Alana Eastaugh, Lisa Taylor, Josephine Baker, Nicola McGuinn, Louise Rath, Vicki Maltby, Maria Pia Sormani, Helmut Butzkueven, Anneke Van der Walt, Dana Horakova, Vilija G Jokubaitis

Journal article  |  2020  |  JAMA Neurology

Importance: Multiple sclerosis (MS) is usually diagnosed in women during their childbearing years. Currently, no consensus exists ..

The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis

Michael Zhong, Anneke van der Walt, Maria Pia Campagna, Jim Stankovich, Helmut Butzkueven, Vilija Jokubaitis

Journal article  |  2020  |  Neurotherapeutics

There are a broad range of disease-modifying therapies (DMTs) available in relapsing-remitting multiple sclerosis (RRMS), but limi..

MSCOVID19: Using social media to achieve rapid dissemination of health information

Cassie Nesbitt, Louise Rath, Wei Zhen Yeh, Michael Zhong, Robb Wesselingh, Mastura Monif, Janene Richards, Bui Minh Viet, Vilija G Jokubaitis, Olga Skibina, Helmut Butzkueven, Anneke van der Walt

Journal article  |  2020  |  Multiple Sclerosis and Related Disorders

BACKGROUND AND OBJECTIVE: The global COVID-19 pandemic creates an obvious acute health care resourcing and response problem. The d..

Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis.

Ruth Dobson, Vilija G Jokubaitis, Gavin Giovannoni

Journal article  |  2020  |  Multiple Sclerosis and Related Disorders

BACKGROUND: Women with MS are advised that relapse rates fall during pregnancy and rebound post-partum. This advice originates fro..

MS, pregnancy and COVID-19.

Charmaine Yam, Vilija Jokubaitis, Kerstin Hellwig, Ruth Dobson

Journal article  |  2020  |  Multiple Sclerosis Journal

Concerns regarding infection with the novel coronavirus SARS-CoV-2 leading to COVID-19 are particularly marked for pregnant women ..

Immunoregulatory effects and therapeutic potential of vitamin D in multiple sclerosis

Wei Zhen Yeh, Melissa Gresle, Vilija Jokubaitis, Jim Stankovich, Anneke van der Walt, Helmut Butzkueven

Journal article  |  2020  |  British Journal of Pharmacology

Initially recognised as an important factor for bone health, Vitamin D is now known to have a range of effects on the immune syste..

Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score

Amy Kunchok, Jeannette Lechner-Scott, Franco Granella, Maria Trojano, Raed Alroughani, Patrizia Sola, Diana Ferraro, Alessandra Lugaresi, Marco Onofrj, Serkan Ozakbas, Guillermo Izquierdo, Pierre Grammond, Jose Luis Sanchez-Menoyo, Bart Van Wijmeersch, Cavit Boz, Eugenio Pucci, Pamela McCombe, Francois Grand'Maison, Daniele Spitaleri, Steve Vucic, et al.

Journal article  |  2020  |  Multiple Sclerosis Journal

BACKGROUND: The magnetic resonance imaging in multiple sclerosis (MAGNIMS) score combines relapses and magnetic resonance imaging ..

Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells

Melissa M Gresle, Margaret A Jordan, Jim Stankovich, Tim Spelman, Laura J Johnson, Louise Laverick, Alison Hamlett, Letitia D Smith, Vilija G Jokubaitis, Josephine Baker, Jodi Haartsen, Bruce Taylor, Jac Charlesworth, Melanie Bahlo, Terence P Speed, Matthew A Brown, Judith Field, Alan G Baxter, Helmut Butzkueven

Journal article  |  2020  |  Life Science Alliance

At least 200 single-nucleotide polymorphisms (SNPs) are associated with multiple sclerosis (MS) risk. A key function that could me..